NCT00311844View on ClinicalTrials.gov

A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209)

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

March 1, 2005

Primary Completion Date

May 28, 2005

Study Completion Date

May 28, 2005

Conditions
Conjunctivitis, Allergic
Interventions
DRUG

desloratadine

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00311844 - A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209) | Biotech Hunter | Biotech Hunter